Daros AC

No ORCID on file · 1 paper in corpus · active 2020
2020
BMC cancer ·doi:10.1186/s12885-020-6670-5

BackgroundConsidering the potential of p16 as a marker for diagnosis, prognosis and therapeutic response, the aim of this study was to assess its presence, via immunocytochemistry, in metastatic carcinoma of different primary sites and hist…